Success Stories: Securing NIW Approval Through Breakthrough Research in Cellular Reprogramming and Aging with NAILG’s Help
Client’s Testimonial:
“Overall experience is 10/10.”
On February 10th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Researcher in the Field of Biomedical Sciences (Approval Notice).
General Field: Biomedical Sciences
Position at the Time of Case Filing: Researcher
Country of Origin: Taiwan
State of Residence at the Time of Filing: Wisconsin
Approval Notice Date: February 10th, 2025
Processing Time: 1 year, 23 days (Premium Processing Requested)
Case Summary:
A promising researcher in biomedical sciences has secured EB-2 NIW (National Interest Waiver) approval with the support of NAILG. Focused on the development of genetically modified cell lines, the client’s work is helping to unlock new treatments for infertility, aging, and age-related diseases such as neurodegeneration. His research integrates cutting-edge approaches in cellular reprogramming and stem cell biology to address some of the most pressing public health challenges of our time.
Research with Substantial Merit and National Importance & Well Positioned to Advance the Proposed Endeavor:
Upon reviewing the client’s background, NAILG recognized the profound national importance of his proposed endeavor: the development of advanced genetically modified cell lines to explore mechanisms of aging, stem cell function, and cellular reprogramming. This work aims to lead to new therapies for infertility, neurodegeneration, and other age-related conditions, issues that are gaining urgency as the aging population continues to grow.
The client’s research stands out for its long-term implications in reducing the socioeconomic toll of age-related diseases and improving the well-being of older adults. His work has received substantial backing from prestigious institutions, including the Howard Hughes Medical Institute (HHMI), the National Institutes of Health (NIH), the Welch Foundation, the American Federation for Aging Research (AFAR), and March of Dimes (MOD) - further validating its national significance.
To support the petition, NAILG presented a strong record of academic productivity and evidence of the client’s growing influence in the biomedical field. The client has authored 6 peer-reviewed journal articles, 2 of which are first-authored, as well as 1 preprint. His publications have been cited 56 times, demonstrating engagement from other researchers working in reproductive health, regenerative medicine, and aging science.
NIW Approval and Outlook:
A compelling expert testimonial emphasized the value of the client’s contributions: "As a talented scientist who has made important contributions to our understanding of the metabolic processes implicated in reproductive health and healthy aging, [client] is performing work of tremendous benefit." With this strong evidence, NAILG successfully secured EB-2 NIW approval for the client, enabling him to continue his promising research in the United States. We are proud to have played a role in supporting this researcher’s pursuit of transformative biomedical advancements.